Dosage Information for Tagrisso: Forms, Strengths, Usage Guidelines, and Additional Details
Tagrisso is a brand-name prescription medication used to treat certain types of non-small cell lung cancer (NSCLC) in adults with EGFR-positive NSCLC. The generic equivalent for Tagrisso is osimertinib mesylate, and generic versions will be marketed under this name once they become available.
The typical dosage for adults with EGFR-positive NSCLC, whether it has been surgically removed or has spread, is 80 mg once per day. Tagrisso can be taken with or without food.
It's important to note that side effects can occur with Tagrisso and may require dosage adjustments or temporary discontinuation. If you experience severe side effects, your doctor may need to adjust your dosage. Missing a dose should be avoided, and if it happens, you should take your next scheduled dose as usual without taking a double dose.
Certain medications can make Tagrisso less effective, and your doctor may increase your dosage to 160 mg if you take Rimactane (rifampin) or Dilantin (phenytoin).
Tagrisso comes as an oral tablet in two strengths: 40 milligrams (mg) and 80 mg. If you have trouble swallowing tablets, Tagrisso can be mixed in plain, noncarbonated water and taken through a nasogastric tube (a tube that goes from your nose into your stomach).
To help ensure you don't miss a dose, you can use a medication reminder, such as setting an alarm or using a reminder app on your phone. If you're having trouble reading your prescription label, talk with your doctor or pharmacist about options like labels with large print, braille, or a code you scan with a smartphone to convert text to speech.
It's crucial to never change your dosage of Tagrisso without consulting your doctor. If you take more than the recommended amount, call your doctor right away or contact the American Association of Poison Control Centers at 800-222-1222 or use its online tool.
The NSCLC must be EGFR-positive, meaning it contains versions of the EGFR protein that tell the cells to keep growing and spreading. For more information about Tagrisso, you can refer to additional articles on the topic, such as one that provides more details about Tagrisso or one that discusses its side effects.
If you have trouble opening medication bottles, ask your pharmacist about putting Tagrisso in an easy-open container or tools that can make it easier to open bottles. If you have further questions or concerns about Tagrisso, it's always best to consult with your healthcare provider.
Scientists have been studying Tagrisso in relation to medical-conditions like cancer, particularly non-small cell lung cancer (NSCLC), due to its effectiveness against EGFR-positive NSCLC. To manage health-and-wellness when taking Tagrisso, it's crucial to follow dosage instructions carefully, as this medication can interact with certain drugs (such as Rimactane or Dilantin) and may potentially lead to anthrax-like side effects that necessitate dosage adjustments or temporary discontinuation.
